MENU
+Compare
RXL
ETF ticker: NYSE ARCA
AS OF
Jun 3, 03:31 PM (EDT)
Price
$39.83
Change
+$0.43 (+1.09%)
Net Assets
64.34M

RXL stock forecast, quote, news & analysis

The investment seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the S&P Health Care Select Sector Index... Show more

Category: #Trading
RXL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for RXL with price predictions
Jun 02, 2025

RXL in +2.07% Uptrend, rising for three consecutive days on May 30, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where RXL advanced for three days, in of 332 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 53 cases where RXL's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for RXL just turned positive on May 27, 2025. Looking at past instances where RXL's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

RXL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on June 02, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on RXL as a result. In of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RXL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Unitedhealth Group (NYSE:UNH), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), ABBVIE (NYSE:ABBV), Abbott Laboratories (NYSE:ABT), Pfizer (NYSE:PFE), Amgen (NASDAQ:AMGN), Intuitive Surgical (NASDAQ:ISRG), Elevance Health (NYSE:ELV).

Industry description

The investment seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the S&P Health Care Select Sector Index. The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index is designed to measure the performance of health care companies included in the S&P 500 Index. Under normal circumstances, the fund will obtain leveraged exposure to at least 80% of its total assets in components of the index or in instruments with similar economic characteristics. The fund is non-diversified.

Market Cap

The average market capitalization across the ProShares Ultra Health Care ETF is 88.51B. The market cap for tickers in the group ranges from 7.65B to 739.66B. LLY holds the highest valuation in this group at 739.66B. The lowest valued company is TECH at 7.65B.

High and low price notable news

The average weekly price growth across all stocks in the ProShares Ultra Health Care ETF was 5%. For the same ETF, the average monthly price growth was 26%, and the average quarterly price growth was 28%. HOLX experienced the highest price growth at 14%, while REGN experienced the biggest fall at -17%.

Volume

The average weekly volume growth across all stocks in the ProShares Ultra Health Care ETF was 7%. For the same stocks of the ETF, the average monthly volume growth was -16% and the average quarterly volume growth was 14%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 46
P/E Growth Rating: 100
Price Growth Rating: 53
SMR Rating: 100
Profit Risk Rating: 65
Seasonality Score: 31 (-100 ... +100)
View a ticker or compare two or three
RXL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Trading

Profile
Fundamentals
Details
Category
Trading--Leveraged Equity
Address
ProShares Trust7501 Wisconsin Avenue,Suite 1000Bethesda
Phone
N/A
Web
www.proshares.com